The purpose of this legislation, known as the Finn Sawyer Access to Cancer Testing Act, is to improve access to cancer diagnostic and laboratory tests for patients, particularly those covered by Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). The act aims to facilitate the development of cancer treatments by ensuring that patients have access to essential testing that can guide their treatment plans. Key provisions of the act include the expansion of coverage for cancer diagnostic and laboratory tests under Medicare and Medicaid.